Indeed, although different molecular mechanisms exist for the development of resistant tumors [11,20,21,22], they remain addicted to the proliferative activities driven by the ERα, which as a transcription factor, regulates the expression of the genes required for cell proliferation in both the primary and the metastatic tumor context [23]. This evidence concerns the gene ESR1 and metastatic neoplasm.